Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-01

Clinical Trial Update: Study to Gather Information About the Safety of Oral Anticoagulation Drugs and How Well These Drugs Work in Real World for Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem)

View source ↗

Summary

A Bayer-sponsored real-world study evaluating the safety and effectiveness of oral anticoagulants in patients with non-valvular atrial fibrillation has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral anticoagulants

Snippet

Sponsor: Bayer | Conditions: Atrial Fibrillation | Status: COMPLETED